IMVT
ImmunovantยทNASDAQ
--
--(--)
--
--(--)
IMVT Profile
Immunovant, Inc.
A clinical-stage biopharmaceutical company that developing therapies for autoimmune diseases
1000 Park Forty Plaza, Suite 210, Durham, NC 27713
--
Immunovant, Inc., incorporated in Delaware on December 6, 2018, is a clinical-stage biopharmaceutical company focused on providing a normal life for patients with autoimmune diseases.
